Obstructive sleep apnoea prevalence in non-arteritic anterior ischaemic optic neuropathy

Aims The aim of this study was to show the prevalence of obstructive sleep apnoea (OSA) in non-arteritic anterior ischaemic optic neuropathy (NAION). Methods 20 patients diagnosed with NAION were included in the study. 20 age and sex matched subjects with similar risk factors for NAION, such as diab...

Full description

Saved in:
Bibliographic Details
Published inBritish journal of ophthalmology Vol. 97; no. 2; pp. 206 - 209
Main Authors Arda, Hatice, Birer, Serife, Aksu, Murat, Ismailogulları, Sevda, Karakucuk, Sarper, Mirza, Ertugrul, Gumus, Koray, Oner, Ayse
Format Journal Article
LanguageEnglish
Published BMA House, Tavistock Square, London, WC1H 9JR BMJ Publishing Group Ltd 01.02.2013
BMJ Publishing Group
BMJ Publishing Group LTD
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Aims The aim of this study was to show the prevalence of obstructive sleep apnoea (OSA) in non-arteritic anterior ischaemic optic neuropathy (NAION). Methods 20 patients diagnosed with NAION were included in the study. 20 age and sex matched subjects with similar risk factors for NAION, such as diabetes mellitus (DM) and hypertension (HT), constituted the control group. All cases underwent polysomnography for investigation of the presence of OSA. Cases with an Apnoea–Hypopnoea Index >5 were accepted as having OSA. Results Mean ages of the patients and controls were 60.90±8.14 and 61.15±7.23 years, respectively. There were no significant differences between the patient and control groups in terms of age, gender, body mass index, smoking/alcohol consumption or systemic diseases. In the patient group, 85% were diagnosed with OSA compared with 65% in the control group (p>0.05). Conclusions We found a high prevalence of OSA in patients with NAION but it was also high in the control group (p>0.05). This may be due to the fact that the two groups were matched for the same risk factors for NAION. The study indicates that OSA is not a risk factor for NAION in itself but is the contributing factor as it has effects on the vascular endothelium in DM, HT and atherosclerosis.
Bibliography:ArticleID:bjophthalmol-2012-302598
PMID:23203698
istex:583391961F46BFCE3ADA72B6CCC75DCD9521D546
local:bjophthalmol;97/2/206
ark:/67375/NVC-QZX0MK9V-S
href:bjophthalmol-97-206.pdf
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Feature-1
content type line 23
ISSN:0007-1161
1468-2079
1468-2079
DOI:10.1136/bjophthalmol-2012-302598